ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.69
0.27%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.40097
-0.12%
Bitcoin
95,152.85
-0.86%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) News

LUNG

Pulmonx (LUNG)

Pulmonx Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LUNG
DateTimeSourceHeadlineSymbolCompany
11/26/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
11/22/20243:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
11/20/20243:05PMGlobeNewswire Inc.Pulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
11/19/20248:00AMBusiness WirePulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersNASDAQ:LUNGPulmonx Corporation
11/14/20246:47PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LUNGPulmonx Corporation
11/07/20243:05PMGlobeNewswire Inc.Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUNGPulmonx Corporation
11/05/20243:05PMGlobeNewswire Inc.Pulmonx to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
11/01/20243:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
10/30/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
10/30/20243:05PMGlobeNewswire Inc.Pulmonx Reports Third Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
10/21/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
10/17/20243:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
10/16/20243:05PMGlobeNewswire Inc.Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LUNGPulmonx Corporation
09/18/20245:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
09/12/20243:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
09/09/20243:05PMGlobeNewswire Inc.Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024NASDAQ:LUNGPulmonx Corporation
09/05/20245:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
09/05/20245:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
08/29/20243:05PMGlobeNewswire Inc.Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceNASDAQ:LUNGPulmonx Corporation
08/22/20245:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
08/22/20243:05PMGlobeNewswire Inc.Pulmonx to Present at the 2024 Wells Fargo Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
08/02/20243:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
07/31/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
07/31/20243:05PMGlobeNewswire Inc.Pulmonx Reports Second Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
07/29/20243:05PMGlobeNewswire Inc.Pulmonx to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:LUNGPulmonx Corporation
07/10/20243:05PMGlobeNewswire Inc.Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:LUNGPulmonx Corporation
06/05/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/05/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/05/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/05/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
 Showing the most relevant articles for your search:NASDAQ:LUNG

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
USOTC
SANP
Santo Mining (CE)
USOTC
TSOI
Therapeutic Solutions (PK)
NYSE
IONQ
IonQ
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
NB
NioCorp Developments
NASDAQ
AMRN
Amarin
USOTC
MONI
Moon Equity (PK)
USOTC
GDVM
Global Developments (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
USOTC
ENZC
Enzolytics (PK)
USOTC
AZRH
Azure (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49